Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA BIOCON ALEMBIC PHARMA/
BIOCON
 
P/E (TTM) x 41.6 36.9 112.9% View Chart
P/BV x 2.2 4.1 54.3% View Chart
Dividend Yield % 1.7 0.2 947.6%  

Financials

 ALEMBIC PHARMA   BIOCON
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
BIOCON
Mar-22
ALEMBIC PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,090424 257.0%   
Low Rs672315 213.4%   
Sales per share (Unadj.) Rs269.968.2 396.0%  
Earnings per share (Unadj.) Rs26.28.2 321.9%  
Cash flow per share (Unadj.) Rs40.814.9 273.4%  
Dividends per share (Unadj.) Rs10.000.50 2,000.0%  
Avg Dividend yield %1.10.1 838.8%  
Book value per share (Unadj.) Rs266.568.5 388.8%  
Shares outstanding (eoy) m196.561,200.60 16.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.35.4 60.2%   
Avg P/E ratio x33.645.3 74.1%  
P/CF ratio (eoy) x21.624.7 87.2%  
Price / Book Value ratio x3.35.4 61.3%  
Dividend payout %38.16.1 621.4%   
Avg Mkt Cap Rs m173,172443,622 39.0%   
No. of employees `000NANA-   
Total wages/salary Rs m11,33018,801 60.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,05881,840 64.8%  
Other income Rs m5056,891 7.3%   
Total revenues Rs m53,56388,731 60.4%   
Gross profit Rs m8,74113,827 63.2%  
Depreciation Rs m2,8688,142 35.2%   
Interest Rs m177676 26.2%   
Profit before tax Rs m6,20111,900 52.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0452,115 49.4%   
Profit after tax Rs m5,1579,785 52.7%  
Gross profit margin %16.516.9 97.5%  
Effective tax rate %16.817.8 94.8%   
Net profit margin %9.712.0 81.3%  
BALANCE SHEET DATA
Current assets Rs m29,74883,823 35.5%   
Current liabilities Rs m18,30638,280 47.8%   
Net working cap to sales %21.655.6 38.8%  
Current ratio x1.62.2 74.2%  
Inventory Days Days11101 10.5%  
Debtors Days Days692 6.0%  
Net fixed assets Rs m42,554117,184 36.3%   
Share capital Rs m3936,003 6.5%   
"Free" reserves Rs m51,98276,281 68.1%   
Net worth Rs m52,37582,284 63.7%   
Long term debt Rs m039,985 0.0%   
Total assets Rs m72,302201,007 36.0%  
Interest coverage x36.018.6 193.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.70.4 180.2%   
Return on assets %7.45.2 141.8%  
Return on equity %9.811.9 82.8%  
Return on capital %12.210.3 118.4%  
Exports to sales %43.80-   
Imports to sales %12.77.8 163.2%   
Exports (fob) Rs m23,251NA-   
Imports (cif) Rs m6,7286,360 105.8%   
Fx inflow Rs m23,2518,885 261.7%   
Fx outflow Rs m6,7286,360 105.8%   
Net fx Rs m16,5232,525 654.4%   
CASH FLOW
From Operations Rs m5,52411,766 46.9%  
From Investments Rs m-3,720-16,991 21.9%  
From Financial Activity Rs m-2,1742,421 -89.8%  
Net Cashflow Rs m-370-2,433 15.2%  

Share Holding

Indian Promoters % 69.1 39.7 174.2%  
Foreign collaborators % 0.5 21.0 2.4%  
Indian inst/Mut Fund % 17.9 23.6 75.9%  
FIIs % 5.3 15.8 33.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 39.4 77.2%  
Shareholders   103,811 369,816 28.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on ALEMBIC PHARMA vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Biocon Share Price Performance

Period ALEMBIC PHARMA Biocon S&P BSE HEALTHCARE
1-Day 0.87% -0.63% -0.10%
1-Month -2.19% 5.56% -1.99%
1-Year -25.46% -22.75% -5.62%
3-Year CAGR 2.57% -0.26% 20.96%
5-Year CAGR 3.16% -11.19% 11.47%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

Biocon paid Rs 0.5, and its dividend payout ratio stood at 6.1%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.